文献速递肝胆胰外科胃肠外科

早发性与晚发性结直肠癌肝转移切除术后的临床病理特征、基因组特征及结局比较

Clinicopathologic characteristics, genomic signatures, and outcomes of patients undergoing resection for early- versus late-onset colorectal liver metastasis.
PubMed 文献 · Surgery · 2025-11-28

该多中心回顾性研究纳入2000-2023年接受治愈性肝切除术的2465例单纯结直肠癌肝转移患者,其中早发性484例(19.6%)、晚发性1981例(80.4%)。早发性患者更多为女性、原发灶位于直肠/左半结肠、伴淋巴结转移及同时性肝转移,但5年无复发生存率(24.2% vs 24.8%)和总生存率(49.4% vs 48.1%)与晚发性无差异,关键基因突变率亦相当。

要点

  • 早发性结直肠癌肝转移患者具有更侵袭性的临床病理特征。
  • 早发与晚发患者肝切除术后5年无复发生存和总生存无显著差异。
  • 年龄本身不应作为结直肠癌肝转移侵袭性和预后不良的指标。

核心结论

  • 尽管早发性结直肠癌肝转移患者临床病理特征更具侵袭性,但其肝切除术后结局和基因组谱与晚发性患者相似。
  • 年龄本身不应被视为结直肠癌肝转移患者侵袭性疾病和不良预后的指标。

研究设计与样本

  • 多中心数据库回顾性研究,纳入2000-2023年接受治愈性肝切除术的单纯结直肠癌肝转移患者2465例。
  • 早发性结直肠癌肝转移定义为年龄较轻发病,共484例(19.6%);晚发性1981例(80.4%)。
  • 基因组特征分析使用美国癌症研究协会GENIE和MSK-CHORD数据库数据。

主要发现

  • 早发性患者更多为女性(46.9% vs 38.0%)、原发灶位于直肠/左半结肠(74.8% vs 68.7%)、伴淋巴结转移(57.4% vs 48.2%)及同时性肝转移(65.8% vs 58.1%),均P < .05。
  • 早发与晚发患者5年无复发生存率分别为24.2%和24.8%,5年总生存率分别为49.4%和48.1%,差异均无统计学意义(P > .05)。
  • 调整相关临床病理特征后,无复发生存风险比1.12(95%CI 0.92-1.37),总生存风险比1.03(95%CI 0.76-1.39)。
  • GENIE和MSK-CHORD队列中,早发与晚发样本在KRAS、BRAF、APC、TP53、PI3K3CA和SMAD4等关键基因突变率相当(所有q > 0.05)。

关键数值与推荐

  • 早发性结直肠癌肝转移患者中女性占46.9%,晚发性中占38.0%。
  • 早发性患者原发灶位于直肠/左半结肠者占74.8%,晚发性占68.7%。
  • 早发性患者伴淋巴结转移者占57.4%,晚发性占48.2%。
  • 早发性患者伴同时性肝转移者占65.8%,晚发性占58.1%。
  • 早发与晚发患者5年无复发生存率分别为24.2%和24.8%,5年总生存率分别为49.4%和48.1%。

临床怎么用

  • 对于早发性结直肠癌肝转移患者,不应仅因年龄因素而判断预后更差或采取更激进的策略。
  • 早发性患者肝切除术后生存与晚发性相似,可参照相同标准进行手术评估和随访。

局限性

  • 回顾性研究设计可能存在选择偏倚和混杂因素。
  • 基因组分析基于外部数据库队列,非同一研究人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While the incidence of early-onset colorectal cancer has increased over the last decade, survival outcomes of patients with early-onset versus late-onset colorectal liver metastases have not been well defined. We sought to assess differences in clinical and molecular characteristics of patients with colorectal liver metastases relative to age at disease onset. METHODS: Patients with liver-only colorectal liver metastases who underwent curative-intent hepatectomy in 2000-2023 were identified in a multi-institutional database. Differences in clinicopathologic characteristics and outcomes of patients with early-onset and late-onset colorectal liver metastases were assessed. Genomic signatures were examined using data from the American Association for Cancer Research GENIE and MSK-CHORD databases. RESULTS: Among 2,465 patients who underwent hepatectomy for colorectal liver metastases, 484 (19.6%) patients had early-onset colorectal liver metastases, and 1,981 (80.4%) had late-onset colorectal liver metastases. Patients with early-onset colorectal liver metastases more frequently were female (46.9% vs 38.0%), had a primary colorectal cancer located in the rectum/left colon (74.8% vs 68.7%), had lymph node metastasis associated with the primary tumor (57.4% vs 48.2%), and had synchronous colorectal liver metastases (65.8% vs 58.1%) compared with patients with late-onset colorectal liver metastases (all P < .05). No differences in 5-year recurrence-free survival (24.2% vs 24.8%) and overall survival (49.4% vs 48.1%) were noted after hepatectomy for early-onset versus late-onset colorectal liver metastases (both P > .05), even after adjusting for relevant clinicopathologic characteristics (recurrence-free survival: hazard ratio 1.12, 95% confidence interval 0.92-1.37; overall survival: hazard ratio 1.03, 95% confidence interval 0.76-1.39). Using the American Association for Cancer Research GENIE and MSK-CHORD cohorts, early-onset and late-onset colorectal liver metastases samples had comparable mutation rates in key genes including KRAS, BRAF, APC, TP53, PI3K3CA, and SMAD4 (all q > 0.05) CONCLUSION: Despite the presence of more aggressive clinicopathologic features, patients with early-onset colorectal liver metastases had outcomes and genomic profiles similar to patients with late-onset colorectal liver metastases. These data highlight how age at disease onset per se should not be considered an indicator of aggressive disease and poor prognosis among patients with colorectal liver metastases.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Tsilimigras DI, Ntanasis-Stathopoulos I, Chatzipanagiotou OP, et al. Clinicopathologic characteristics, genomic signatures, and outcomes of patients undergoing resection for early- versus late-onset colorectal liver metastasis. Surgery. 2025. PMID: 41314946. doi:10.1016/j.surg.2025.109897

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。